AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 292: H2425-H2431, 2007. First published January 19, 2007; doi:10.1152/ajpheart.01197.2006
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/H2425    most recent
01197.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt-Lucke, C.
Right arrow Articles by Dimmeler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt-Lucke, C.
Right arrow Articles by Dimmeler, S.

Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients

Caroline Schmidt-Lucke ,1,* Alexandra Aicher,1,* Paola Romagnani,2 Björn Gareis,1 Sergio Romagnani,2 Andreas M. Zeiher,1 and Stefanie Dimmeler1

1Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, Frankfurt, Germany, 2Division of Clinical Immunology and Allergy, University of Florence, Florence, Italy

Submitted 1 November 2006 ; accepted in final form 9 January 2007

Regulatory T cells (Treg) migrate into allografts and induce tolerance of the graft. Immunosuppressive Treg are found among CD4+CD25++ T cells and specifically express the forkhead/winged transcription factor FOXP3. We hypothesized that activated T cells and Treg might modulate the ongoing inflammation of the cardiac allograft (CA) and that the chronic inflammatory environment might influence the balance between these distinct cell types. We therefore quantified levels of activated T cells and CD4+CD25++ Treg in the cardiac and systemic circulation in heart transplant recipients. To determine the influence of the allograft passage on these cells, transcardiac gradients were evaluated in CA recipients (n = 22) compared with controls (n = 18). Systemic levels of circulating Treg were significantly lower in CA recipients (8.9 ± 1.3 µl) compared with controls (15.8 ± 1.6 µl; P = 0.002). Similarly, the proportion of Treg related to the total leukocyte number was significantly lower in CA recipients (P < 0.01). In contrast, systemic levels of circulating activated CD4+ T cells and of circulating plasmacytoid dendritic cells were similar in both groups. In transplant patients, numbers of Treg significantly decreased during transcardiac passage (3.0 ± 0.3 to 2.4 ± 0.3% of CD4+ T cells, P < 0.01), and FOXP3+ T cells invaded into the allograft. In contrast, numbers of activated CD4+ T cells increased during passage through the allograft, even in the presence of effective immunosuppression. In conclusion, numbers of circulating immunosuppressive Treg are reduced in transplant recipients. Recruitment of Treg into the cardiac allograft during transcoronary passage may induce graft tolerance during subclinical inflammation potentially influencing allograft vasculopathy.

coronary circulation; chronic inflammation



Address for reprint requests and other correspondence: S. Dimmeler or A. M. Zeiher, Dept. of Internal Medicine III, Division of Cardiology, J. W. Goethe Univ., Theodor-Stern-Kai 7, 60590 Frankfurt, Germany (e-mail: dimmeler{at}em.uni-frankfurt.de; zeiher{at}em.uni-frankfurt.de)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.